Today: 7 February 2026
Subscribe

Abivax (ABVX) Stock in Focus: Eli Lilly Takeover Chatter, Obefazimod Phase 3 Momentum, and What to Watch Before the Next U.S. Session

Abivax (ABVX) Stock in Focus: Eli Lilly Takeover Chatter, Obefazimod Phase 3 Momentum, and What to Watch Before the Next U.S. Session

NEW YORK — Friday, December 26, 2025 (9:13 a.m. ET): U.S. stocks are heading into a thin, post‑Christmas trading day, with Wall Street set for a relatively muted open as investors digest a strong 2025 tape and look ahead to 2026 rate and earnings narratives. Reuters In that kind of tape, headline-driven biotech names can swing harder than usual—and ABIVAX Société Anonyme (NASDAQ: ABVX) has been exactly that kind of stock in December: a mix of clinical-trial enthusiasm, index-related positioning, and renewed takeover speculation. As of the latest available quote this morning, ABVX was trading around $145.31 in the premarket,
26 December 2025
······
POSCO Holdings Stock (NYSE: PKX) in Focus Ahead of the U.S. Open: Louisiana Green-Steel Bet, Lithium Supply Deals, and What Investors Are Watching

POSCO Holdings Stock (NYSE: PKX) in Focus Ahead of the U.S. Open: Louisiana Green-Steel Bet, Lithium Supply Deals, and What Investors Are Watching

NEW YORK — As of 9:17 a.m. ET on Friday, December 26, 2025, U.S. markets are in the final stretch of the year with thin, post-Christmas liquidity and a “Santa rally” narrative in play, while stock index futures point to a nearly flat open. Reuters For POSCO Holdings Inc. (NYSE: PKX)—the U.S.-listed ADR of South Korea’s steel-and-materials group—the timing matters: the NYSE regular session hasn’t opened yet (the opening bell is 9:30 a.m. ET), so headline-driven moves can look bigger than they really are when volume is light. Below is what’s driving the POSCO story right now, what analysts are
26 December 2025
··
NVIDIA Stock (NVDA) 26.12.2025: Groq Inference Licensing Deal, Analyst Targets, and What to Watch Before the Next Market Open

NVIDIA Stock (NVDA) 26.12.2025: Groq Inference Licensing Deal, Analyst Targets, and What to Watch Before the Next Market Open

NVIDIA Corporation (NASDAQ: NVDA) is in focus heading into the close of Friday, 26.12.2025, as investors digest a headline-grabbing AI inference technology licensing deal with Groq—and the market tries to extend a strong year-end run amid thin post-holiday liquidity. The twist: early reports framed the Groq news as a blockbuster acquisition, but Groq and multiple follow-up reports have emphasized a different structure—a non-exclusive licensing agreement plus key Groq executives joining NVIDIA, while Groq continues as an independent company. Groq Below is what matters most after today’s opening bell—and what to keep on your radar before the next U.S. market session
26 December 2025
·····
Zai Lab Limited Stock (NASDAQ: ZLAB) Today: Pre‑Market Watchlist After China’s COBENFY Approval, NRDL Renewals, and Fresh Pipeline Catalysts

Zai Lab Limited Stock (NASDAQ: ZLAB) Today: Pre‑Market Watchlist After China’s COBENFY Approval, NRDL Renewals, and Fresh Pipeline Catalysts

New York — Friday, December 26, 2025, 9:08 a.m. ET. U.S. equities are not yet in the regular session as of this writing; the Nasdaq opens at 9:30 a.m. ET. Barron’s That timing matters today because Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is entering the session with multiple company-specific catalysts on the board—most notably China’s approval of COBENFY for schizophrenia, plus updates tied to China’s National Reimbursement Drug List (NRDL) and progress in a key oncology program (zocilurtatug pelitecan, “zoci”). Business Wire Meanwhile, the broader market backdrop is very “holiday week”: thin liquidity, a post‑Christmas reset, and investors still
26 December 2025
·····
Tesla Stock (TSLA) After the Bell Today 26.12.2025: NHTSA Model 3 Door Probe, Robotaxi Deadline Buzz, and What to Watch Before the Next Market Open

Tesla Stock (TSLA) After the Bell Today 26.12.2025: NHTSA Model 3 Door Probe, Robotaxi Deadline Buzz, and What to Watch Before the Next Market Open

December 26, 2025 (26.12.2025) — Tesla, Inc. (NASDAQ: TSLA) is back in the spotlight in a thin, post-holiday trading week, with investors weighing two competing narratives: fresh regulatory scrutiny tied to the Model 3, and renewed optimism that Tesla’s autonomy and AI roadmap could re-rate the company beyond “just an automaker.” Investopedia At the time of writing, the U.S. regular session is still underway (the 4:00 p.m. ET closing bell hasn’t happened yet), meaning the true “after-the-bell” reaction will come later today. Still, today’s news flow has already laid out the catalysts most likely to drive post-market headlines and set
26 December 2025
·····
Edgewise Therapeutics (EWTX) Stock Surges on EDG-7500 Safety Update as Wall Street Prepares to Reopen After Christmas

Edgewise Therapeutics (EWTX) Stock Surges on EDG-7500 Safety Update as Wall Street Prepares to Reopen After Christmas

As of 8:54 a.m. ET in New York on Friday, December 26, 2025, U.S. stock exchanges have not yet opened for the regular session (standard hours are 9:30 a.m. to 4:00 p.m. ET). Nasdaq Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is in focus heading into the post-holiday session after the company delivered an encouraging clinical update for EDG-7500—its investigational therapy for hypertrophic cardiomyopathy (HCM)—that helped drive a sharp rally in the last session before Christmas. PR Newswire Where EWTX stock stands pre-market Market data tracked by MarketBeat shows EWTX closing at $27.38 on December 24 (the last regular session before Christmas
26 December 2025
·····
Oracle Stock Heads for Worst Quarter Since 2001 as AI Spending Fears Collide With OpenAI, TikTok, and Hollywood Bets

Oracle Stock Heads for Worst Quarter Since 2001 as AI Spending Fears Collide With OpenAI, TikTok, and Hollywood Bets

Oracle (NYSE: ORCL) is closing out 2025 with the kind of volatility normally reserved for pure-play AI startups, not a 47-year-old enterprise software heavyweight. Shares are down about 30% so far this quarter, putting the stock on pace for its steepest quarterly decline since 2001, according to market reporting that tracked the move against Oracle’s early-2000s drawdowns. StockAnalysis The selloff has been fueled by a single, recurring question: Can Oracle finance—and execute—an AI data-center buildout big enough to meet demand without crushing its cash flow and balance sheet? That concern has only intensified as Oracle’s ambitions expand beyond the cloud.
26 December 2025
·····
Almonty Industries (ALM) Stock Today: Sangdong Tungsten Milestone, Fresh Funding, Analyst Targets, and What to Watch Before the Open

Almonty Industries (ALM) Stock Today: Sangdong Tungsten Milestone, Fresh Funding, Analyst Targets, and What to Watch Before the Open

New York time: 8:56 a.m. ET on Friday, December 26, 2025. With U.S. markets heading into a thinly traded post‑Christmas session, Almonty Industries Inc. (NASDAQ: ALM) is landing in front of investors at a moment when “materials” stories can move fast: the company has just hit a major operational milestone at its flagship Sangdong tungsten mine in South Korea and has recently completed a sizeable U.S. equity raise to fund a broader tungsten pipeline. Reuters Below is a news-and-forecast round‑up focused on what matters right now—before the next regular trading session begins. Is the stock market open right now? At
26 December 2025
······
Travere Therapeutics (TVTX) Stock Watch: Pre‑Market Focus on the Jan. 13 FDA Decision After a 14% Rally

Travere Therapeutics (TVTX) Stock Watch: Pre‑Market Focus on the Jan. 13 FDA Decision After a 14% Rally

As of 8:54 a.m. ET in New York on Friday, December 26, 2025, U.S. markets are in pre‑market and set to reopen for the regular session at 9:30 a.m. ET. Travere Therapeutics, Inc. (NASDAQ: TVTX) is entering the post‑holiday session with fresh momentum and a very specific catalyst on investors’ minds: an FDA decision deadline of January 13, 2026 for expanding FILSPARI (sparsentan) into focal segmental glomerulosclerosis (FSGS)—a high‑stakes regulatory event that can move a biotech stock in either direction. Travere Therapeutics TVTX stock: where it stands heading into today’s open TVTX’s most recent regular-session close (Christmas Eve, Dec. 24)
26 December 2025
····
American Airlines Will Hold Some Flights for Tight Connections: How the New Connect Assist “Short Hold” Service Works, Where It’s Live, and What Travelers Should Know

American Airlines Will Hold Some Flights for Tight Connections: How the New Connect Assist “Short Hold” Service Works, Where It’s Live, and What Travelers Should Know

Missing a connection is one of air travel’s most infuriating moments: your first flight is late, you land already behind schedule, and your next plane is pushing back just as you reach the gate. American Airlines says it’s trying to reduce that pain point—by using an AI-driven system that can briefly hold certain departing flights for late-arriving connecting passengers when doing so won’t disrupt the broader operation. AFAR Media The move is designed for a very specific scenario: tight connections that are still realistically makeable—if the airline can buy you a few extra minutes without triggering cascading delays across the
26 December 2025
··
UiPath (PATH) Stock News Today: S&P MidCap 400 Addition, Latest Earnings Outlook, and Analyst Price Targets Ahead of the Dec. 26 Open

UiPath (PATH) Stock News Today: S&P MidCap 400 Addition, Latest Earnings Outlook, and Analyst Price Targets Ahead of the Dec. 26 Open

New York time check: It is 8:55 a.m. ET on Friday, December 26, 2025 in New York. With U.S. markets reopening after the Christmas holiday, UiPath Inc. (NYSE: PATH) is back in the spotlight—thanks to a fresh index-inclusion catalyst, a sharper profitability narrative from its most recent quarter, and a market backdrop that’s setting up for thin, post-holiday trading. Stock market status in New York right now As of 8:55 a.m. ET, the regular NYSE/Nasdaq session has not opened yet (the core session runs 9:30 a.m. to 4:00 p.m. ET). New York Stock ExchangePre-market trading is active (typically 4:00 a.m.
26 December 2025
···
Polestar Stock (PSNY) News Today: Fresh Funding, Reverse Split Fallout, and What Investors Should Watch Before the Dec. 26 Open

Polestar Stock (PSNY) News Today: Fresh Funding, Reverse Split Fallout, and What Investors Should Watch Before the Dec. 26 Open

NEW YORK — As of 9:00 a.m. ET on Friday, December 26, 2025, the U.S. stock market has not opened for the regular session yet (9:30 a.m.–4:00 p.m. ET), and trading conditions are typically thinner than usual in the post-Christmas stretch. Reuters Against that backdrop, Polestar Automotive Holding UK PLC (Nasdaq: PSNY) is entering the day with investors focused on three big themes: a liquidity lifeline backed by Geely, the company’s recent 1-for-30 reverse split/ADS ratio change, and the ongoing tug-of-war between growing sales and still-painful losses in a highly competitive EV market. PSNY was indicated around $17.18 in the
26 December 2025
····
1 … 1,211 1,212 1,213 1,214 1,215 … 2,713

Stock Market Today

Stellantis stock rattled by $26.5 billion EV reset and dividend halt ahead of Monday trade

Stellantis stock rattled by $26.5 billion EV reset and dividend halt ahead of Monday trade

7 February 2026
Milan, February 7, 2026, 10:54 (CET) — Market closed. Stellantis shares (STLA) closed at $7.28 in New York on Friday, down 23.8%, after the Jeep maker unveiled a €22.2 billion ($26.5 billion) hit tied to scaling back electric-vehicle plans and said it would not pay a dividend in 2026. The selloff matters going into next week because it forces a quick rethink on cash and capital returns at a company investors once treated as a high-yield play. With markets shut for the weekend, traders will be looking for any follow-through from credit markets and analysts before Monday’s open. In Europe,
Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

7 February 2026
Ashtead shares closed Friday at 4,936p, up 1.09%, after the company bought 88,872 shares under its repurchase program. The group is set to shift its primary listing to New York on March 2, pending court approval, and will be removed from the FTSE UK index the same day. Ashtead paid a half-year dividend of 37.5 U.S. cents per share on Friday.
Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

7 February 2026
Beazley shares closed flat at 1,236 pence Friday as BlackRock disclosed a 6.55% stake and Vanguard reported 5.02%. Wellington Management cut its holding below 5%. The disclosures follow Zurich Insurance’s possible takeover offer of up to 1,335 pence per share, with a Feb. 16 deadline for a firm bid.
Go toTop